Aytu Biopharma (AYTU) Total Debt Growth (3y) (2015 - 2026)
Aytu Biopharma (AYTU) Total Debt Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 92.83% |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | -7.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.09% |
| Dec 31, 2025 | 9.26% |
| Sep 30, 2025 | -18.92% |
| Jun 30, 2025 | 3.33% |
| Mar 31, 2025 | -7.23% |
| Dec 31, 2024 | 106.99% |
| Sep 30, 2024 | 46.51% |
| Jun 30, 2024 | -7.64% |
| Mar 31, 2024 | -53.96% |
| Dec 31, 2023 | 5.44% |
| Sep 30, 2023 | 8.68% |
| Jun 30, 2023 | 154.96% |
| Mar 31, 2023 | -16.85% |
| Dec 31, 2022 | -15.34% |
| Sep 30, 2022 | 165.28% |
| Mar 31, 2022 | 33.89% |
| Dec 31, 2021 | -38.10% |
| Sep 30, 2021 | 165.54% |
| Jun 30, 2021 | 213.44% |
| Mar 19, 2021 | 715.30% |